This debilitating neurological disease affects 39 million people in the U.S. yet migraines are often downplayed as simply just a headache.
PharmAvail's CFO Kurt Belluomini breaks down the various stakeholders, the role they play in pricing, and how we help our clients achieve their clinical and financial goals.
Alternate funding has evolved in recent years as a way to help employers match specialty drug costs with funding. Check out this video by our president and chief operating officer, Rich Adams, to learn more.
In this Forbes piece, PharmAvail's President and COO Rich Adams examines the role of PBMs and what the future holds in this dynamic industry.
Introducing PharmAvail's new brand identity and web site! At PharmAvail we love what we do – and it shows. And as you can see from our new brand, we’re passionate about transforming the pharmacy benefit experience.
Did you know there were more prescription drug price increases in January 2021 than any other year in the last decade? PharmAvail's Philip Carroll, director of account management, breaks down what’s happening, why, and the role your PBM partner should play in helping manage these costs.